共 50 条
- [1] The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe [J]. ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
- [3] The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe [J]. Orphanet Journal of Rare Diseases, 11
- [5] Pricing and reimbursement of orphan drugs in Italy [J]. VALUE IN HEALTH, 2006, 9 (06) : A208 - A209
- [6] REIMBURSEMENT OF ORPHAN DRUGS: WHAT IS THE DIFFERENCE? [J]. VALUE IN HEALTH, 2012, 15 (07) : A311 - A311
- [7] PRICING AND REIMBURSEMENT OF ORPHAN DRUGS IN CANADA [J]. VALUE IN HEALTH, 2011, 14 (03) : A29 - A29
- [8] REIMBURSEMENT AND PRICING OF ORPHAN DRUGS IN TAIWAN [J]. VALUE IN HEALTH, 2019, 22 : S856 - S856
- [9] Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe [J]. Orphanet Journal of Rare Diseases, 15